We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Government Chemist team have published a report summarising the findings of a ring trial to assess laboratories’ performance in measuring CBD and controlled cannabinoids
Advisory Council on the Misuse of Drugs (ACMD) call for evidence on cannabinoids in CBD products.
The Medicines and Healthcare products Regulatory Agency has issued an opinion on the regulatory status of products containing CBD
The importer and distributor of the above products (Eaststone Limited) has informed us of reports that two affected batches may be contaminated with mould.
The number of trade marks filed which contain "CBD" either in the trade mark or somewhere in their specification
The VMD considers that veterinary products containing Cannabidiol are veterinary medicines.
Letter from Kit Malthouse MP to Professor Owen Bowden-Jones, Chair of the Advisory Council on the Misuse of Drugs (ACMD).
Employment Tribunal decision.
Specialist clinicians will be able to legally prescribe cannabis-derived medicinal products by the autumn, Home Secretary Sajid Javid announced today.
Cannabis-based products for medicinal use will be available for specialist doctors to prescribe legally.
With government support Seaweed & Co.'s overseas sales now account for 15% of its turnover, shipping its milled seaweed ingredients to customers worldwide.
Patients can be prescribed medicinal cannabis by specialist doctors from 1 November 2018.
The Advisory Council on the Misuse of Drugs response to the consultation by NICE on the draft scope of their guidance on cannabis-based products for medicinal use.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).